Avisar, Hila
Guardia-Laguarta, Cristina
Surface, Matthew http://orcid.org/0000-0002-4933-2618
Papagiannakis, Nikos http://orcid.org/0000-0002-8401-8472
Maniati, Matina
Antonellou, Roubina
Papadimitriou, Dimitra
Koros, Christos
Athanassiadou, Aglaia
Przedborski, Serge
Lerner, Boaz
Stefanis, Leonidas http://orcid.org/0000-0003-3569-8990
Area-Gomez, Estela
Alcalay, Roy N. http://orcid.org/0000-0002-5717-4875
Funding for this research was provided by:
Parkinson's Foundation (Stanley Fahn Junior Faculty Award)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (K02NS080915, AG056387)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
Article History
Received: 10 October 2021
Accepted: 31 March 2022
First Online: 25 April 2022
Competing interests
: L.S. was supported in part for this work through the Hellenic Ministry of Education and Religion THALIS grant number 377206 and from the EU Program MEFOPA (FP7-HEALTH-241791). R.N.A. is funded by the NIH, DoD, the Parkinson’s Foundation, and the Michael. J. Fox Foundation. He received consultation fees from Avrobio, Caraway, GSK, Merck, Ono Therapeutics, and Genzyme/Sanofi. The other authors declare no competing interests.